Raffles Medical Group Ltd
SGX:BSL

Watchlist Manager
Raffles Medical Group Ltd Logo
Raffles Medical Group Ltd
SGX:BSL
Watchlist
Price: 0.975 SGD -1.02% Market Closed
Market Cap: 1.8B SGD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one BSL stock under the Base Case scenario is 1.038 SGD. Compared to the current market price of 0.975 SGD, Raffles Medical Group Ltd is Undervalued by 6%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BSL Relative Value
Base Case
1.038 SGD
Undervaluation 6%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.4
P/S
P/S
Price to Sales
2.4
vs History
88
vs Industry
41
Median 3Y
2.7
Median 5Y
2.9
Industry
2.2
Forward
2.3
More Details
29.1
P/E
P/E
Price to Earnings
29.1
vs History
23
vs Industry
19
Median 3Y
22.3
Median 5Y
25.5
Industry
22.1
Forward
25.7
More Details
21
P/OCF
P/OCF
Price to OCF
21
vs History
4
vs Industry
17
Median 3Y
13.4
Median 5Y
13.5
Industry
13.9
More Details
49.7
P/FCFE
P/FCFE
Price to FCFE
49.7
vs History
4
vs Industry
9
Median 3Y
30.6
Median 5Y
24.5
Industry
19.7
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
79
vs Industry
45
Median 3Y
2
Median 5Y
2.2
Industry
2.1
More Details
2.2
EV/S
EV/S
Enterprise Value to Sales
2.2
vs History
90
vs Industry
44
Median 3Y
2.5
Median 5Y
2.8
Industry
2.4
Forward
2.1
More Details
2.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.5
vs History
84
vs Industry
62
Median 3Y
2.9
Median 5Y
3.4
Industry
4.9
More Details
12.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.8
vs History
47
vs Industry
26
Median 3Y
11.5
Median 5Y
12.8
Industry
11.6
Forward
12.2
More Details
19.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19.3
vs History
39
vs Industry
22
Median 3Y
15.7
Median 5Y
18.2
Industry
15.7
Forward
18.1
More Details
19.1
EV/OCF
EV/OCF
Enterprise Value to OCF
19.1
vs History
4
vs Industry
20
Median 3Y
12.4
Median 5Y
13.1
Industry
13.9
More Details
25.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
25.2
vs History
23
vs Industry
18
Median 3Y
14.5
Median 5Y
21.2
Industry
17.3
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
69
vs Industry
41
Median 3Y
1.9
Median 5Y
1.9
Industry
1.8
More Details

Multiples Across Competitors

BSL Competitors Multiples
Raffles Medical Group Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
SG
Raffles Medical Group Ltd
SGX:BSL
1.8B SGD 2.4 29.1 12.8 19.3
US
HCA Healthcare Inc
NYSE:HCA
90.4B USD 1.2 15.7 9.2 12.2
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 8.3 42.2 35.6 42.8
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
20.5B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
19.2B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
116.3B CNY 5.3 31.4 25 25.3
US
Tenet Healthcare Corp
NYSE:THC
15B USD 0.8 10.3 6 7.6
MY
IHH Healthcare Bhd
KLSE:IHH
60.7B MYR 2.5 25.3 12.1 17.6
BR
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
79.1B BRL 1.5 19.4 7.7 9.3
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1.1T INR 16.4 106.8 65.8 79.5
US
Encompass Health Corp
NYSE:EHC
12.1B USD 2.2 24.6 11.7 15.5

See Also

Summary
BSL intrinsic value, competitors valuation, and company profile.
DCF Valuation
BSL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BSL stock valuation using valuation multiples.
Wall Street Estimates
BSL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BSL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 260,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.